Boston Scientific Corporation · BSX · Next earnings
Boston Scientific Corporation reports Wednesday, Feb 3, 2027
BSX reports before market open with consensus EPS at $0.79 and revenue at $5.20B. Last quarter: Boston Scientific: Cyber Incident Weighs on Q3; 2027 Outlook Softens
What the street expects
Consensus for the coming reportWhere BSX left off: FY2026 Q3
Full reportBoston Scientific: Cyber Incident Weighs on Q3; 2027 Outlook Softens
Management maintained full-year 2026 guidance at approximately 4% organic revenue growth and EPS of $3.16-$3.18, while the analysis points to flat or declining EPS growth in 2027 as EP and WATCHMAN face pressure.
What to watch on the call
Carried forward from the last transcriptAsk FN2 about BSX next report
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Get the BSX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Recent BSX quarters
All BSX earningsSources
- FN2 corporate events calendar, resolved from the earnings calendar feed
- FN2 earnings calendar analyst consensus
- Earnings call transcript analysis, FY2026 Q3
Methodology
The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.
Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.